Acorda Therapeutics, Inc.
Methods for cardiomyocyte survival, proliferation or differentiation by NRG-2

Abstract:

The invention features methods of treatment and diagnosis using NRG-2 polypeptides, nucleic acid molecules, and antibodies. The invention also provides novel NRG-2 polypeptides and nucleic acid molecules.